Zim Laboratories balance sheet

As of Mar 2026

Total assets: ₹539cr+14.3% on Mar 2025
Shareholders' equity: ₹296cr+17.4% on Mar 2025
Total debt: ₹123cr+9.6% on Mar 2025
Cash and investments: ₹25.1cr+1,190.6% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Non-current assets
	156	158	157	104
	58.8	44.1	23.5	17.8
	0.2	0.2	0.2	0.2
	5.2	5.8	3.7	4.8
	36.8	26.4	18.8	9.2
	0.1	0.1	0.1	0.1
	3.5	1.0	0.8	0.9
	3.6	1.1	0.8	1.0
	0.5	0.0	0.0	0.0
	2.2	4.9	15.2	14.0
	264	241	219	151
Current assets
	93.8	86.5	81.3	53.7
	109	107	100	95.2
	25.1	1.9	9.6	6.4
	18.3	0.5	0.9	1.1
	0.0	0.0	0.0	0.0
	0.5	0.3	0.3	0.1
	153	110	111	103
	29.1	35.1	35.4	34.3
	276	231	228	191
	539	472	447	342
Equity
	53.5	48.7	48.7	48.7
	243	204	190	152
	296	252	239	200
	0.0	0.0	0.0	0.0
	296	252	239	200
Liabilities
	41.6	40.3	35.6	24.6
	0.8	2.1	2.9	1.0
	42.4	42.4	38.6	25.6
	10.4	11.1	10.1	4.8
	52.8	53.4	48.7	30.4
	81.4	71.9	70.8	34.9
	72.9	69.5	62.4	58.2
	13.4	15.3	13.2	10.0
	168	157	146	103
	0.9	0.7	0.8	0.6
	2.6	2.9	0.0	0.0
	19.2	6.1	12.2	7.1
	190	166	159	111
	243	220	208	141
	539	472	447	342
Trade payables — MSME split
	8.5	6.7	—	—
	64.5	62.8	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZIMLAB₹141.26

Zim Laboratories Limited

· Pharma & Health

₹ CrorePeersANUHPHR VALIANTLAB AHCL ALBERTDAVD WANBURY HALEOSLABS BAJAJHCARE THEMISMEDMcap ₹756 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	103.7	156.9	158.3	156.4	156.4
+ Capital Work-in-Progress	17.8	23.5	44.1	58.8	58.8
+ Goodwill	0.2	0.2	0.2	0.2	0.2
+ Other Intangibles	4.8	3.7	5.8	5.2	5.2
+ Intangibles under Development	9.2	18.8	26.4	36.8	36.8
+ Non-current Investments	0.1	0.1	0.1	0.1	0.1
+ Other Non-current Financial Assets	0.9	0.8	1.0	3.5	3.5
Non-current Financial Assets	1.0	0.8	1.1	3.6	3.6
+ Deferred Tax Assets	0.0	0.0	0.0	0.5	0.5
+ Other Non-current Assets	14.0	15.2	4.9	2.2	2.2
Total Non-current Assets	150.6	219.2	240.7	263.6	263.6
Current Assets
+ Inventories	53.7	81.3	86.5	93.8	93.8
+ Trade Receivables	95.2	100.2	106.9	109.0	109.0
+ Cash & Cash Equivalents	6.4	9.6	1.9	25.1	25.1
+ Other Bank Balances	1.1	0.9	0.5	18.3	18.3
+ Short-term Loans	0.0	0.0	0.0	0.0	0.0
+ Other Current Financial Assets	0.1	0.3	0.3	0.5	0.5
Current Financial Assets	102.9	110.9	109.7	152.9	152.9
+ Other Current Assets	34.3	35.4	35.1	29.1	29.1
Total Current Assets	190.9	227.6	231.3	275.8	275.8
Total Assets	341.6	446.8	472.0	539.4	539.4
Equity
+ Equity Share Capital	48.7	48.7	48.7	53.5	53.5
+ Other Equity / Reserves	151.6	190.0	203.5	242.7	242.7
Equity — Owners of Parent	200.3	238.7	252.2	296.2	296.2
+ Minority Interest	0.0	0.0	0.0	0.0	0.0
Total Equity	200.3	238.7	252.2	296.2	296.2
Liabilities
+ Borrowings — Non-current	24.6	35.6	40.3	41.6	41.6
+ Other Non-current Financial Liab	1.0	2.9	2.1	0.8	0.8
Non-current Financial Liabilities	25.6	38.6	42.4	42.4	42.4
+ Deferred Tax Liabilities	4.8	10.1	11.1	10.4	10.4
Non-current Liabilities	30.4	48.7	53.4	52.8	52.8
+ Borrowings — Current	34.9	70.8	71.9	81.4	81.4
+ Trade Payables	58.2	62.4	69.5	72.9	72.9
+ Other Current Financial Liab	10.0	13.2	15.3	13.4	13.4
Current Financial Liabilities	103.1	146.4	156.6	167.8	167.8
+ Provisions — Current	0.6	0.8	0.7	0.9	0.9
+ Current Tax Liabilities	0.0	0.0	2.9	2.6	2.6
+ Other Current Liabilities	7.1	12.2	6.1	19.2	19.2
Current Liabilities	110.8	159.4	166.4	190.4	190.4
Total Liabilities	141.2	208.1	219.8	243.2	243.2
Total Equity & Liabilities	341.6	446.8	472.0	539.4	539.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	6.7	8.5	8.5
+ Dues to Other Creditors — Current	—	—	62.8	64.5	64.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.